Comparison of Cefuroxime‐Based Dual Therapy With Quadruple Therapy in Helicobacter pylori‐Infected Treatment‐Naive Patients: A Prospective, Multicenter, Randomized Controlled Trial

Documenti analoghi

• Efficacy and Safety of Vonoprazan‐Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial
  di: Jin‐Yan Zhang, et al.
  Pubblicazione: (2026)
• Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial
  di: Tian‐Lian Yan, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Vonoprazan‐Based Dual Therapies With Different Antibiotics Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four‐Arm, Randomized Controlled Trial
  di: Jie Li, et al.
  Pubblicazione: (2026)
• Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled Trial
  di: Yu‐Ming Ding, et al.
  Pubblicazione: (2024)
• Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China
  di: Xueyan Lin, et al.
  Pubblicazione: (2024)